Delays in Initiating Therapy for Inflammatory Bowel Disease

This chapter explores the delays in starting effective drug therapies for patients with inflammatory bowel disease, discussing the impact of various factors such as race, distance from medical center, and insurance approval. The speakers suggest strategies to minimize delays and address potential disparities in treatment outcomes.